CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home Marken Chosen for Key Study on Mount Everest
News
31 Jan 2017

Marken Chosen for Key Study on Mount Everest

Irreplaceable Blood Samples from Nepal are Shipped to Canada

Marken has successfully completed shipments originating from Mount Everest as part of an important research program designed to study the effects of high altitude on the human body. 

Blood samples were collected from 67 subjects at various altitudes on the mountain and then transported to Kathmandu and on to a laboratory in Canada.  The subjects were accompanied by Sherpa and an expedition team from the University of British Columbia. Study participants donated 3000 vials of blood taken at a variety of altitudes. The blood samples were shipped by helicopter to transport the samples from various higher camps on the mountain to the base camp. Marken collected the samples in Kathmandu and shipped them over a weekend in a frozen state to the University of British Columbia for testing.  

Marken took responsibility for managing the shipments during the lengthy trip from Nepal through Turkey and on to Canada. Marken’s Global Control Center in Mumbai tracked the shipment in real time through every leg of the journey. The Mumbai team monitors all shipments into and out of the region and transmits data through its proprietary Maestro operating system. Maestro is supported by its exclusive Sentry device which monitors GPS location, temperature, altitude, light exposure and shock.

“We congratulate the expedition team and the study participants on this successful undertaking while overcoming adverse weather conditions and navigating difficult terrain in order to achieve the study goals,” said Wes Wheeler, Chief Executive Officer for Marken, “I also want to acknowledge the commitment of our Marken team members who made it happen for our clients.  We are privileged to be entrusted with a shipment of this importance, and I’m pleased to share results that highlight how our team members continue to go above and beyond every day to support important clinical research.” 

About Marken
Marken is a wholly owned subsidiary of UPS.  Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistic hubs in 45 locations worldwide for clinical trial material storage and distribution. Marken’s more than 750 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries.  Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.

CONTACT: Christine Noble, [email protected], +1 919 474 6890, www.marken.com

Mentioned Companies
Marken LLP
View company profile